Blog

The online pharmacy and independent testing company Valisure discovered the presence of the human carcinogen N-nitrosodimethylamine (NDMA) in Valsartan and Zantac and recently alerted the FDA to the presence of the human carcinogen benzene in many popular sunscreens. Valisure’s Citizen Petition  On May 24, 2021, Valisure filed a Citizen Petition with the U.S. Food and Drug Administration about its findings. As a result of the…

A recent talcum powder lawsuit in California settled mid-trial after the plaintiff put forth significant evidence to prove the talcum powder she used contained asbestos. Asbestos exposure has been proven to be toxic and potentially fatal. It has been connected to mesothelioma–a fatal cancer of the tissue lining the heart, lungs, and other organs–and…

The COVID-19 pandemic continues to shift the landscape of litigation. As more hearings and trials are being conducted virtually, the likelihood of virtual judicial proceedings even after the pandemic has increased. As the landscape of litigation continues to evolve, you need a law firm that understands the changing nature of the litigation landscape due…

Popular rheumatoid arthritis, psoriatic arthritis, and ulcerative medication Xeljanz has been potentially linked to MACE injuries, strokes, and blood clots through a clinical study. These injuries require extensive treatment. For additional information on the Xeljanz lawsuits, see our Xeljanz Area of Practice page. Treatment for MACE Injuries Major Adverse Cardiac Events (MACE) injuries include: Heart…

Popular rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis medication Xeljanz has been potentially linked to causing strokes and blood clots. Review our Xeljanz Safety Evaluation Timeline for more information on the approval history of Xeljanz and the study potentially connecting Xeljanz to strokes and blood clots. Xeljanz is also linked to Major Adverse Cardiac Events (MACE)…

Xeljanz and MACE Injuries Preliminary results from an FDA-mandated study conducted by Xeljanz and Xeljanz XR’s manufacturer, Pfizer, found that patients taking the popular rheumatoid arthritis medication are at an increased risk of developing serious heart-related injuries.  Xeljanz is also used to treat psoriatic arthritis and ulcerative colitis. The preliminary results of the study were concerning…